论文部分内容阅读
目的:观察子宫肌瘤应用不同剂量米非司酮治疗的临床效果。方法:选取2013年2月--2014年2月间我院收治的子宫肌瘤患者55例,分为两组。对照组给予大剂量的米非司酮治疗,观察组给予小剂量的米非司酮治疗,对比两组治疗效果。结果:观察组子宫体积、子宫肌瘤体积与对照组比较相对较小(P<0.05);两组血红蛋白水平与闭经发生率差异较小(P>0.05);观察组各项激素指标良好,不良反应相对较少(P<0.05)。结论:子宫肌瘤应用小剂量米非司酮治疗能够明显缩小子宫肌瘤的体积,调整激素水平,效果良好,安全性高,值得推广。
Objective: To observe the clinical effect of different doses of mifepristone in treating uterine fibroids. Methods: 55 cases of uterine leiomyoma admitted to our hospital from February 2013 to February 2014 were divided into two groups. The control group was given high-dose mifepristone treatment, the observation group was given a small dose of mifepristone treatment, the treatment effect of two groups were compared. Results: The volume of uterus and uterine fibroids in the observation group were relatively smaller than those in the control group (P <0.05). There was no significant difference between the two groups in the incidence of amenorrhea (P> 0.05) The response was relatively small (P <0.05). Conclusion: The treatment of uterine fibroids with low dose of mifepristone can significantly reduce the volume of uterine fibroids, adjust the hormone levels, the effect is good, safe and worthy of promotion.